Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
23.54
+0.99 (4.39%)
At close: Oct 15, 2026, 4:00 PM EDT
23.00
-0.54 (-2.29%)
After-hours: Oct 15, 2026, 7:30 PM EDT
Elanco Animal Health Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, Elanco Animal Health stock has a consensus rating of "Buy" and an average price target of $31. The average 1-year stock price forecast is 31.69% higher than the current stock price, while the lowest is $26 (+10.45%) and the highest is $34 (+44.44%).
Price Target: $31 (+31.69%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Elanco Animal Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 10 | 10 |
| Buy | 5 | 5 | 5 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 17 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Reiterates $34 | Buy | Reiterates | $34 | +44.44% | Oct 1, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 18, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $32 | Buy | Reiterates | $32 | +35.94% | Aug 24, 2026 |
| Barclays | Barclays | Buy Maintains $30 | Buy | Maintains | $30 | +27.44% | Aug 21, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $32 → $34 | Buy | Maintains | $32 → $34 | +44.44% | Aug 13, 2026 |
Financial Forecast
Revenue This Year
5.12B
from 4.72B
Increased by 8.66%
Revenue Next Year
5.39B
from 5.12B
Increased by 5.29%
EPS This Year
1.13
from 0.94
Increased by 20.72%
EPS Next Year
1.28
from 1.13
Increased by 13.22%
EPS and Forward PE are based on non-GAAP adjusted numbers.